Literature DB >> 15251414

Single step high-throughput determination of Toll-like receptor 4 polymorphisms.

Bas B van Rijn1, Mark Roest, Arie Franx, Hein W Bruinse, Hieronymus A M Voorbij.   

Abstract

BACKGROUND: Toll-like receptors are central components of host defence in humans, responsible for recognition of pathogen-associated molecular patterns and activation of innate immunity. Toll-like receptor 4 (TLR4) is activated by lipopolysaccharide (LPS) and other microbial components, thereby initiating the expression and release of pro-inflammatory cytokines. The common, frequently co-segregating allelic variants Asp299Gly and Thr399Ile have been related to susceptibility to gram-negative infections and sepsis and may be involved in the development of atherosclerosis. Identification of TLR4 Asp299Gly and Thr399Ile genotypes can be important for examination of genotype/phenotype relationships as well as for individual risk assessment of patients.
METHODS: TLR4 Asp299Gly and Thr399Ile genotypes were detected by a single tube polymerase chain reaction (PCR), based on exonuclease degradation of dual labelled allele-specific oligonucleotides. The assay results were compared with conventional restriction fragment length polymorphism (RFLP) analysis.
RESULTS: Genotypes of 345 individuals were determined simultaneously in a single PCR assay. Allele frequencies for our population were 6.8% for the TLR4 Asp299Gly polymorphism and 6.4% for the Thr399Ile polymorphism. Validation by RFLP analysis revealed a correct detection of all genotypes.
CONCLUSIONS: We have developed a novel method for the detection of the TLR4 Asp299Gly and Thr399Ile mutations, permitting rapid genotyping which should be useful for large-scale population studies as well as applicable for routine clinical testing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15251414     DOI: 10.1016/j.jim.2004.03.013

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients.

Authors:  M Veltkamp; J C Grutters; C H M van Moorsel; H J T Ruven; J M M van den Bosch
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

2.  Maternal TLR4 and NOD2 gene variants, pro-inflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome.

Authors:  Bas B van Rijn; Arie Franx; Eric A P Steegers; Christianne J M de Groot; Rogier M Bertina; Gerard Pasterkamp; Hieronymus A M Voorbij; Hein W Bruinse; Mark Roest
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.